10-4965991-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_001353.6(AKR1C1):c.162A>T(p.Leu54Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,614,196 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001353.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKR1C1 | NM_001353.6 | c.162A>T | p.Leu54Phe | missense_variant | 2/9 | ENST00000380872.9 | NP_001344.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKR1C1 | ENST00000380872.9 | c.162A>T | p.Leu54Phe | missense_variant | 2/9 | 1 | NM_001353.6 | ENSP00000370254.4 |
Frequencies
GnomAD3 genomes AF: 0.000801 AC: 122AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000895 AC: 225AN: 251414Hom.: 1 AF XY: 0.000868 AC XY: 118AN XY: 135874
GnomAD4 exome AF: 0.00118 AC: 1732AN: 1461858Hom.: 4 Cov.: 30 AF XY: 0.00110 AC XY: 802AN XY: 727224
GnomAD4 genome AF: 0.000801 AC: 122AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000832 AC XY: 62AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2024 | The c.162A>T (p.L54F) alteration is located in exon 2 (coding exon 2) of the AKR1C1 gene. This alteration results from a A to T substitution at nucleotide position 162, causing the leucine (L) at amino acid position 54 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at